Antonin de Fougerolles appointed Chairman of Lift Therapeutics Board
1 report, 1 independent
Updated Sep 23
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Antonin de Fougerolles was appointed Chairman of the Board of Lift Therapeutics on September 23, 2026. He joined Daniel Passeri as Chief Executive Officer and Dr. Bo Rode Hansen, who is resuming his role on the Board of Directors as President.
From manilatimes.net
Why it matters
The leadership changes occur as Lift Therapeutics prepares to advance its iMAN program into first-in-human studies in early 2027. The iMAN platform is described as a potential therapeutic breakthrough in cancer treatment.
From manilatimes.net
Who's involved
- Antonin de FougerollesChairman of the Board of Lift Therapeutics
- LIFTBiotechnology company preparing to advance cancer immunotherapy research
Keep exploring
The entities involved
-
LIFT
organization
Nothing else this week.